Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Needle vs. scalpel: which dialysis access works best?

NCT ID NCT05654103

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 39 times

Summary

This study compares two methods for creating an arteriovenous fistula (AVF) in people with end-stage kidney disease who need dialysis. The newer endovascular method uses a needle through the skin, while the traditional surgical method requires an incision. Researchers will enroll 90 patients who qualify for both procedures and randomly assign them to one method, tracking how well the fistula matures and how long it lasts. The goal is to gather data for a larger study to determine which approach is better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE ON DIALYSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UCLA Division of Vascular and Endovascular Surgery Clinic

    RECRUITING

    Los Angeles, California, 90095, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Pittsburgh Medical Center

    RECRUITING

    Pittsburgh, Pennsylvania, 15231, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

endoAVF device and surgical AVF procedure

What this could lead to

If this trial succeeds, it could show that the newer needle-based method for creating dialysis access is as good as or better than surgery, potentially offering a less invasive option for kidney patients.

What could go wrong

This is a small pilot study with only 90 participants, so results may not apply to everyone. The newer method may require more follow-up procedures, and it's too early to know which approach is truly better.

Conditions

The condition(s) this trial relates to.

chronic kidney disease congenital arteriovenous fistula end stage renal failure Fistula

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.